A detailed history of Putnam Investments LLC transactions in Kiniksa Pharmaceuticals, Ltd. stock. As of the latest transaction made, Putnam Investments LLC holds 39,486 shares of KNSA stock, worth $787,350. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,486
Previous 40,742 3.08%
Holding current value
$787,350
Previous $707,000 2.12%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$14.37 - $19.07 $18,048 - $23,951
-1,256 Reduced 3.08%
39,486 $692,000
Q3 2023

Nov 14, 2023

SELL
$13.62 - $20.2 $4,780 - $7,090
-351 Reduced 0.85%
40,742 $707,000
Q2 2023

Aug 14, 2023

SELL
$10.44 - $16.48 $13,373 - $21,110
-1,281 Reduced 3.02%
41,093 $578,000
Q1 2023

May 22, 2023

BUY
$10.7 - $15.79 $197,168 - $290,962
18,427 Added 76.95%
42,374 $455,000
Q4 2022

Feb 14, 2023

BUY
$11.42 - $17.05 $273,474 - $408,296
23,947 New
23,947 $358,000

Others Institutions Holding KNSA

About Kiniksa Pharmaceuticals, Ltd.


  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $687M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Putnam Investments LLC Portfolio

Follow Putnam Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.